Technical Analysis for MRSN - Mersana Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 4.76 5.78% 0.26
MRSN closed up 5.78 percent on Tuesday, April 23, 2019, on 1.53 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical MRSN trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Pocket Pivot Bullish Swing Setup 5.78%
Bollinger Band Squeeze Range Contraction 5.78%
Hammer Candlestick Bullish 6.73%
Bollinger Band Squeeze Range Contraction 6.73%
BB Squeeze + Lower Band Touch Range Contraction 6.73%
Lower Bollinger Band Touch Weakness 6.73%
Bollinger Band Squeeze Range Contraction 4.62%
NR7 Range Contraction 4.62%

Older signals for MRSN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mersana Therapeutics, Inc. is a United States-based biotechnology company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies. XMT-1522 is based on its Dolaflexin platform and has over 15 auristatin molecules per antibody. XMT-1522 is in Phase I clinical trial for various indications of cancers. XMT-1536 is in pre-clinical development.
Medicine Biotechnology Cancer Immunology Cancers Chemotherapy Monoclonal Antibodies Antibody Drug Conjugates Adc
Is MRSN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.96
52 Week Low 2.845
Average Volume 255,358
200-Day Moving Average 7.8487
50-Day Moving Average 5.2862
20-Day Moving Average 4.843
10-Day Moving Average 4.642
Average True Range 0.365
ADX 21.6
+DI 15.331
-DI 24.429
Chandelier Exit (Long, 3 ATRs ) 4.305
Chandelier Exit (Short, 3 ATRs ) 5.235
Upper Bollinger Band 5.3496
Lower Bollinger Band 4.3364
Percent B (%b) 0.42
BandWidth 20.920917
MACD Line -0.1445
MACD Signal Line -0.136
MACD Histogram -0.0085
Fundamentals Value
Market Cap 108.11 Million
Num Shares 22.7 Million
EPS -16.23
Price-to-Earnings (P/E) Ratio -0.29
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.23
Resistance 3 (R3) 5.19 5.01 5.15
Resistance 2 (R2) 5.01 4.89 5.02 5.12
Resistance 1 (R1) 4.88 4.82 4.95 4.92 5.10
Pivot Point 4.70 4.70 4.73 4.71 4.70
Support 1 (S1) 4.57 4.58 4.64 4.61 4.42
Support 2 (S2) 4.39 4.51 4.40 4.40
Support 3 (S3) 4.26 4.39 4.37
Support 4 (S4) 4.30